OVERVIEW FROM THE INTERNATIONAL-CONFERENCE ON LONG-TERM TAMOXIFEN THERAPY FOR BREAST-CANCER

[1] INCIDENCE OF NEW PRIMARY CANCERS AFTER ADJUVANT TAMOXIFEN THERAPY AND RADIOTHERAPY FOR EARLY BREAST-CANCER [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (14) : 1013 - 1017

[2] NEW ANTI-OESTROGENIC AGENT IN LATE BREAST CANCER - EARLY CLINICAL APPRAISAL OF ICI46474 [J]. BRITISH JOURNAL OF CANCER, 1971, 25 (02) : 270 - &

[3] ENGSTROM PF, 1990, CANCER, V65, P2641, DOI 10.1002/1097-0142(19900615)65:12<2641::AID-CNCR2820651207>3.0.CO

[4] 2-R

[5] UNRESECTABLE HEPATOCELLULAR-CARCINOMA - A PROSPECTIVE CONTROLLED TRIAL WITH TAMOXIFEN [J]. JOURNAL OF HEPATOLOGY, 1990, 11 (03) : 297 - 301

[6] INHIBITION OF ESTROGEN-RECEPTOR DNA-BINDING BY THE PURE ANTIESTROGEN ICI-164,384 APPEARS TO BE MEDIATED BY IMPAIRED RECEPTOR DIMERIZATION [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6883 - 6887

[7] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) : 479 - 484

[8] FORNANDER T, 1989, LANCET, V1, P117

[9] THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN [J]. PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) : 127 - 205

[10] GOTTARDIS MM, 1990, CANCER RES, V50, P3189

[1] INCIDENCE OF NEW PRIMARY CANCERS AFTER ADJUVANT TAMOXIFEN THERAPY AND RADIOTHERAPY FOR EARLY BREAST-CANCER [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (14) : 1013 - 1017

[2] NEW ANTI-OESTROGENIC AGENT IN LATE BREAST CANCER - EARLY CLINICAL APPRAISAL OF ICI46474 [J]. BRITISH JOURNAL OF CANCER, 1971, 25 (02) : 270 - &

[3] ENGSTROM PF, 1990, CANCER, V65, P2641, DOI 10.1002/1097-0142(19900615)65:12<2641::AID-CNCR2820651207>3.0.CO

[4] 2-R

[5] UNRESECTABLE HEPATOCELLULAR-CARCINOMA - A PROSPECTIVE CONTROLLED TRIAL WITH TAMOXIFEN [J]. JOURNAL OF HEPATOLOGY, 1990, 11 (03) : 297 - 301

[6] INHIBITION OF ESTROGEN-RECEPTOR DNA-BINDING BY THE PURE ANTIESTROGEN ICI-164,384 APPEARS TO BE MEDIATED BY IMPAIRED RECEPTOR DIMERIZATION [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) : 6883 - 6887

[7] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) : 479 - 484

[8] FORNANDER T, 1989, LANCET, V1, P117

[9] THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN [J]. PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) : 127 - 205

[10] GOTTARDIS MM, 1990, CANCER RES, V50, P3189